ARCHIVES

Interview With Departing NCI Director; Advice To His Successor.

This article is from The Cancer Letter archive.

Vol. 36 No. 26 | July 9, 2010

Download PDF Visit The Full Archive

Related Articles

New Chairman Of Core Grant Review Committee Has Some Advice for Applicants

May 5, 1978

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

In Brief: NY Judges, Lawyers Form Breast Cancer Alert; Terms of ODAC Chairman, 3 Members Expire

July 3, 1992

Cancer Letter Goes On Vacation

August 16, 1985

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

September 13, 1985